Navigation Links
PTC Therapeutics Reports Third Quarter 2013 Financial and Corporate Results
Date:11/14/2013

dystrophy confirmatory Phase 3 clinical trial and the initiation of our Phase 3 confirmatory trial in nonsense mutation cystic fibrosis. We also look forward to advancement of our other programs highlighted in our R&D day."

Corporate Highlights:

  • Publications in Muscle and Nerve validating six-minute walk test and describing ambulatory natural history in DMD patients: In August 2013, data published in two manuscripts in the medical journal Muscle & Nerve demonstrated the clinical meaningfulness of the six-minute walk test as a primary endpoint to measure disease progression and walking ability in ambulatory Duchenne muscular dystrophy trials.  The natural history data utilized for the analysis was obtained from PTC's Phase 2b trial of ataluren in 174 patients, the first registration–directed, placebo-controlled, multi-national study of a new chemical entity for DMD.
  • Presentations at multiple scientific conferences:  During the quarter, PTC presented at multiple scientific conferences including the European Pediatric Neurology Society Congress (EPNS), where PTC hosted a symposium titled "New perspectives in the management of Duchenne muscular dystrophy," the World Muscle Society Congress (WMS) and the North American Cystic Fibrosis Conference (NACFC). 
  • Chosen to join the Russell 2000 Index: On September 30th, PTC was added to the Russell 2000 Index.  The Russell 2000® Index, a subset of the Russell 3000® Index, measures the performance of the small-cap segment of the U.S. equity market.
  • Hosted first R&D Day: On October 25th, PTC hosted its first R&D day in New York City where PTC's senior management and research teams presented in-depth reviews of the company's scientific platforms and R&D programs.
  • Confirmatory Phase 3 Trial in nmDMD on track: In April 2013, PTC initiated a confirmatory Phase 3
    '/>"/>

  • SOURCE PTC Therapeutics, Inc.
    Copyright©2012 PR Newswire.
    All rights reserved

    Page: 1 2 3 4 5 6 7

    Related medicine technology :

    1. Aratana Therapeutics Reports Third Quarter 2013 Financial Results
    2. Levi & Korsinsky, LLP Launches Investigation of SAREPTA THERAPEUTICS, INC. for Possible Violations of Federal Securities Laws
    3. Argos Therapeutics to Present at the Elsevier Therapeutic Area Partnerships Meeting
    4. Mirati Therapeutics Reports Third Quarter 2013 Financial Results
    5. Sorrento Therapeutics Adopts Stockholder Rights Plan
    6. Orexigen Therapeutics Reports Business and Financial Results for the Third Quarter Ended September 30, 2013
    7. Shield Therapeutics Files Investigational New Drug Application for ST10 for the Treatment of Iron Deficiency in Chronic Kidney Disease
    8. Cara Therapeutics Files Registration Statement for Proposed Initial Public Offering
    9. Nektar Therapeutics Reports Financial Results for the Third Quarter of 2013
    10. Echo Therapeutics Announces Third Quarter 2013 Financial Results
    11. Halozyme Therapeutics To Present At The Credit Suisse Healthcare Conference
    Post Your Comments:
    *Name:
    *Comment:
    *Email:
    (Date:1/15/2014)... the leading health care supply chain expertise, analytics and ... national contracts that expand its portfolio to provide hospital ... These include manufacturer product and service agreements, as well ... IT consulting support. New Novation agreements ...
    (Date:1/15/2014)... , January 15, 2014 Shire plc (LSE: SHP, ... Office of Fair Trading (OFT) approval condition to the announced tender ... VPHM).   As a result of the waiver, the ... to complete the tender offer on January 24, 2014 following the ...
    (Date:1/15/2014)... , Jan. 15, 2014  Manufacturers, suppliers and distributors ... able to protect their most important business assets, ... ) Because of the highly-competitive ... remains one of the most litigious industry sectors ...
    Breaking Medicine Technology:New Novation Information Technology VAR Contracts Offer Significant Savings to Hospitals 2Shire Waives OFT Condition Relating to the Acquisition of ViroPharma Inc. 2Shire Waives OFT Condition Relating to the Acquisition of ViroPharma Inc. 3Intellectual Property Insurance for Medical-related Products and Services 2
    (Date:7/9/2014)... researchers reveal that sudden, acute episodes of low back ... temperature, humidity, air pressure, wind direction and precipitation. Findings ... journal of the American College of Rheumatology (ACR), indicate ... with higher wind speed or wind gusts, but was ... Health Organization (WHO) nearly everyone experiences low back pain ...
    (Date:7/9/2014)... the Perelman School of Medicine at the University of ... have received an $8 million grant from the National ... light therapy (PDT) in patients with malignant pleural mesothelioma, ... manifests itself in the lining of the lungs and ... grant will fund a clinical trial and additional studies ...
    (Date:7/9/2014)... captures heretofore hidden ways that cells are regulated, scientists ... breast cancer cells more likely to metastasize. , What,s ... part by blocking two other proteins that are normally ... disease processes could have unexpected ties. , The ... Nature , points to the possibility of new ...
    (Date:7/9/2014)... New findings from Fox Chase Cancer Center paint a ... subset of breast cancers that have spread to the ... Tumors that grow into the skin, regardless of size ... classified as stage III and called "locally advanced" ... of cancer, often with poor survival. Locally advanced breast ...
    (Date:7/9/2014)... -- Researchers from The Miriam Hospital have found ... who are also depressed have difficulty sticking to ... particularly true for women, and screening and brief ... of treatment. The study and its findings are ... , Chronic obstructive pulmonary disease is a ...
    Breaking Medicine News(10 mins):Health News:Low back pain? Don't blame the weather 2Health News:Penn mesothelioma program receives $8 million NCI grant 2Health News:Protein pushes breast cancer cells to metastasize 2Health News:Protein pushes breast cancer cells to metastasize 3Health News:Fox Chase researchers recommend updating the staging criteria for breast cancer diagnoses 2Health News:Fox Chase researchers recommend updating the staging criteria for breast cancer diagnoses 3Health News:Miriam Hospital study examines effect of depressed mood on pulmonary rehab completion 2
    ... line of defence in the threat of bio-terrorism according to ... international team of researchers from Cardiff University and University of ... well be an antidote to Bacillus anthracis more commonly know ... currently drink 165 million cups of tea, and the healing ...
    ... at Henry Ford Hospital today announced the start of ... international, multi-center clinical trial to explore an investigational treatment ... suffering with advanced emphysema. The study focuses on a ... in the lung for trapped air (one of the ...
    ... This release is available in French . ... by Universit Laval scientist Marc-Andr Sirard has identified genetic ... best chance of leading to successful pregnancy after in ... success rate of single embryo transfer and diminish the ...
    ... Angeles, March 12 --Combined positron emission tomography (PET) and ... more effective method to evaluate response to radiation therapy, ... study by researchers at the University of Southern California ... be published in the March issue of the journal ...
    ... and obesity training, state,s,largest Medicaid managed care plan now ... provide medical professionals the opportunity to become ... Well, Live Well program, CHARLESTON, W.Va., March 12 ... in the country in asthma prevalence,UniCare Health Plan of ...
    ... TSTF ) a national provider of healthcare and ... the Nasdaq Stock,Market that the Nasdaq Hearings Panel has ... Global Market pending the effectiveness of the,Company,s proposed reverse ... on February 7, 2008. The decision of the Panel ...
    Cached Medicine News:Health News:Is a cup of tea really the answer to everything -- even anthrax? 2Health News:Henry Ford Hospital to study effectiveness of a new procedure that may help emphysema suffers 2Health News:Researchers develop a method to select eggs with the best chance of leading to successful pregnancy 2Health News:USC researchers find benefit for lymphoma patients in combined PET-CT scanning 2Health News:UniCare of West Virginia Providing Assistance for Asthma Education Training 2Health News:UniCare of West Virginia Providing Assistance for Asthma Education Training 3Health News:Nasdaq Hearings Panel Grants TeamStaff's Request for Continued Listing Subject to a Reverse Stock Split 2Health News:Nasdaq Hearings Panel Grants TeamStaff's Request for Continued Listing Subject to a Reverse Stock Split 3
    Ophthalmic Nd Yag Laser with excellent quality optics for clear image and good laser delivery. Compact and light-weight for portability....
    The compact size and portability of the Epic system makes it a cost-effective solution for single or multi-office use....
    A conventional blue visibility-tinted daily-wear lens, custom made for astigmats with up to -3.00 D of cylinder requiring adds of up to +2.50 D....
    A soft contact lens that lets presbyopes see clearly and comfortably at all distances , without the hassles of bifocals or reading glasses. Recommended for daily wear. Also approved for extended wear...
    Medicine Products: